Skip to content
10-Q

Quarterly Report

AIM ImmunoTech Inc. AIM

0001493152-26-023750

← back to feed
Filed
May 15, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 13, 2026 14.56M sh
Shares Diluted Q1 2026 · Mar 31, 2026 4.35M sh
Shares Diluted restated Q1 2026 · Mar 31, 2025 703.3K sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$2.72M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$2.36M
Long Term Debt Q1 2026 · Mar 31, 2026 $210K
Long Term Debt Q1 2026 · Dec 31, 2025 $927K
Cash And Equivalents Q1 2026 · Mar 31, 2026 $5.82M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $2.99M
Stockholders Equity Q1 2026 · Mar 31, 2026 $2.13M
Stockholders Equity Q1 2026 · Dec 31, 2025 −$9.78M
Stockholders Equity Q1 2026 · Mar 31, 2025 −$3.86M
Stockholders Equity Q1 2026 · Dec 31, 2024 −$1.32M
Current Liabilities Q1 2026 · Mar 31, 2026 $6.15M
Current Liabilities Q1 2026 · Dec 31, 2025 $6.22M
Total Liabilities Q1 2026 · Mar 31, 2026 $6.46M
Total Liabilities Q1 2026 · Dec 31, 2025 $15.57M
Current Assets Q1 2026 · Mar 31, 2026 $6.21M
Current Assets Q1 2026 · Dec 31, 2025 $3.3M
Total Assets Q1 2026 · Mar 31, 2026 $8.59M
Total Assets Q1 2026 · Dec 31, 2025 $5.78M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.69
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.05
Eps Basic Q1 2026 · Mar 31, 2026 −$0.69
Eps Basic Q1 2026 · Mar 31, 2025 −$0.05
Sga Expense Q1 2026 · Mar 31, 2026 $1.76M
Sga Expense Q1 2026 · Mar 31, 2025 $2.55M
Rd Expense Q1 2026 · Mar 31, 2026 $482K
Rd Expense Q1 2026 · Mar 31, 2025 $1.08M
Net Income Q1 2026 · Mar 31, 2026 −$3.02M
Net Income Q1 2026 · Mar 31, 2025 −$3.71M
Operating Income Q1 2026 · Mar 31, 2026 −$2.23M
Operating Income Q1 2026 · Mar 31, 2025 −$3.62M
Revenue Q1 2026 · Mar 31, 2026 $22K
Revenue Q1 2026 · Mar 31, 2025 $16K